Industry | 2015.12.01
FDA Clears Siemens CT Scanners for Low-Dose Lung Cancer Screening
MALVERN, Pa.--(BUSINESS WIRE)--The Food and Drug Administration (FDA) has cleared Siemens Healthcare’s SOMATOM computed tomography (CT) systems for low-dose lung cancer screening. Siemens now offers the industry’s most comprehensive approach to low-dose lung cancer screening -- both on all of Siemens’ new CT scanners sold as well as on the company’s installed base of non-end-of-support systems – using standard low-dose lung protocols that are already delivered on Siemens CT scanners. From the S
For more information, please visit
http://www.businesswire.com/news/home/20[...]mens-CT-Scanners-Low-Dose-Lung
